(February 3, 2021)
College of Pharmacy and HOPE Center alumni DAVID RHYS AXON, PhD, MPharm, MS and TERRI WARHOLAK, PhD, RPh co-authored a new study in the Journal of Clinical Lipidology titled A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans. The researchers assessed statin adherence using over a one year period among a cohort of commercially insured patients in the United States. Findings showed that 61.9% of the eligible patients were adherent to the statin medication, which was associated with: fewer inpatient visits; lower outpatient, inpatient, and total costs; and lower per member per month total costs than nonadherence. Co-authors also include College of Pharmacy Health & Pharmaceutical Outcomes Program alumni Patrick Campbell, PhD and Chanadda Chinthammit, PhD , PharmD Program alumnus Seth Anderson, PharmD, MS, and HOPE Center affiliate Ann Taylor, MPH, MCHES.